Latest Customer Contracts News

Wide Open Agriculture has agreed with Curtin University to replace its tiered royalty structure with a single 3.5% flat royalty on net sales, streamlining financial planning and enhancing commercial scalability for its lupin protein technology.

Aurizon reports volume growth across coal, bulk, and container freight for ten months to April, maintaining FY2026 EBITDA and dividend guidance amid a temporary $10 million fuel cost timing hit.

NEXTDC has locked in A$1.8 billion in new senior debt commitments, lifting its total senior debt capacity to A$8.2 billion and pro forma liquidity to about A$8.4 billion. The fresh capital will underpin ongoing data centre development and recent contract wins, with financial close targeted for July 2026.

Peak Processing reported its first positive EBITDA month in March 2026, driven by operational efficiencies and strong production growth. The company upgraded its Q4 production forecast and expanded key customer contracts, signaling a turning point after a challenging period.

Enlitic delivered its strongest quarter yet with A$5.1 million in contracts, including significant agreements with Penn Medicine, St. Jude Children’s Research Hospital, and Parkland Health, while improving cash flow and advancing its AI-powered Ensight platform.

Megaport’s Latitude.sh has secured a $35.4 million three-year compute and storage deal, adding nearly $12 million in annual recurring revenue and underpinning the company’s growth in AI-driven infrastructure.

Saferoads Holdings maintained steady sales in the March quarter with a positive operating cash flow and ongoing product upgrades, despite cost pressures from oil-based materials and uncertainty over future orders from On-site Rentals.

NEXTDC has boosted its pro forma contracted utilisation by 60% to 667MW, prompting a A$1.5 billion entitlement offer and an expanded capital plan to accelerate its Western Sydney data centre developments.

Orora has lowered its FY26 EBIT forecast for its Saverglass business due to direct operational impacts and indirect market shifts stemming from the ongoing Middle East conflict, while maintaining stable guidance for other segments.

Genetic Technologies Limited remains under voluntary administration while progressing a Deed of Company Arrangement and has completed the sale of its geneType business, ending the quarter with $270,000 in cash.

Lynas Rare Earths Ltd has reported a striking half-year turnaround with a 1260% surge in net profit, underpinned by rising rare earth prices and strategic expansions. The company also completed a major equity raise to fuel its ambitious Towards 2030 growth plan.

Artrya Limited reported a 44% increase in its half-year loss to $10.7 million as it transitioned from development to commercial operations in the US, securing FDA clearance and signing three foundation customers. An $80 million capital raise underpins its ambitious US expansion and ongoing product development.